Aurobindo Pharma's Lannett Facility Completes US FDA Inspection with 4 Observations
Aurobindo Pharma’s Lannett facility in Indiana completes a US Food and Drug Administration (FDA) inspection with 4 procedural observations and will respond within the stipulated timeline.
Securities And Exchange Board Of India (SEBI) | 24/08/2026 | By News Bureau
Allchem Lifescience Receives SEBI Nod for INR 190 Crore IPO
Allchem Lifescience Limited, a domestic manufacturer specializing in API intermediates and specialty chemicals, has secured approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering (IPO).
Securities And Exchange Board Of India (SEBI) | 03/09/2025 | By Darshana | 360
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy